Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any cornea plana in which the cause of the disease is a mutation in the KERA gene.
Features include always present findings: Cloudy or opaque cornea (corneal opacity), Microphthalmia, Reduced visual acuity, and Flat cornea and others. 8 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 4 | Decreased corneal thickness, Cloudy or opaque cornea (corneal opacity), Corneal arcus |
KERA encodes keratocan (352 aa). May be important in developing and maintaining corneal transparency and for the structure of the stromal matrix Highest expression in Breast Mammary Tissue (0.3 TPM) and Colon Sigmoid (0.2 TPM).
Cornea plana 2 is associated with mutations in the KERA gene on chromosome 12.
The KERA protein participates in Keratan sulfate/keratin metabolism pathway.
KERA is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for KERA is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 5 always present features.
No clinical trials have been registered for cornea plana 2.
8 publications have been identified in PubMed for cornea plana 2. Research spans Basic Science / Preclinical (38%), Case Report / Case Series (25%), and Epidemiology / Natural History (25%).
Yu Q (2026). [PMID: 41540031](https://pubmed.ncbi.nlm.nih.gov/41540031/). *NPJ Regen Med*. [Basic Science / Preclinical]
Abdalla Elsayed MEA (2026). [PMID: 41550454](https://pubmed.ncbi.nlm.nih.gov/41550454/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Zhu D (2026). [PMID: 41953647](https://pubmed.ncbi.nlm.nih.gov/41953647/). *Mol Vis*. [Basic Science / Preclinical]
Tolman N (2026). [PMID: 41556506](https://pubmed.ncbi.nlm.nih.gov/41556506/). *Elife*. [Basic Science / Preclinical]
Shan K (2026). [PMID: 41738891](https://pubmed.ncbi.nlm.nih.gov/41738891/). *Cornea*. [Clinical Trial Publication]
Calpe E (2025). [PMID: 39259299](https://pubmed.ncbi.nlm.nih.gov/39259299/). *Graefes Arch Clin Exp Ophthalmol*. [Epidemiology / Natural History]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 3:00 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Gabriel BS (2024). [PMID: 38502349](https://pubmed.ncbi.nlm.nih.gov/38502349/). *Graefes Arch Clin Exp Ophthalmol*. [Epidemiology / Natural History]
Hou KK (2024). [PMID: 37603441](https://pubmed.ncbi.nlm.nih.gov/37603441/). *Retin Cases Brief Rep*. [Case Report / Case Series]